Tvardi Therapeutics, Inc.
TVRD- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001346830
No open-market purchases or sales by Tvardi Therapeutics, Inc. insiders were filed in the last 90 days; 57 institutions reported holding it in 13F filings for Q2 2026, worth $4.24M in total; no superinvestor holds it.
13F holders, Q1 2024
Institutional positions in Tvardi Therapeutics, Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 101
- −11 vs. Q4 2023
- Shares held
- 23.6M
- −784.8K (−3.2%) vs. Q4 2023
- Total value
- $21.5M
- +$3.37M (+18.6%) vs. Q4 2023
- New holders
- 13
- 24 more added
- Sold out
- 24
- 33 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TVRD on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 57 | $4.24M |
| Q1 2026 | 67 | $8.60M |
| Q4 2025 | 67 | $12.1M |
| Q3 2025 | 73 | $102.2M |
| Q2 2025 | 56 | $44.9M |
| Q1 2025 | 35 | $3.21M |
| Q4 2024 | 45 | $6.59M |
| Q3 2024 | 71 | $4.17M |
| Q2 2024 | 81 | $4.56M |
| Q1 2024 | 101 | $21.5M |
| Q4 2023 | 112 | $18.1M |
| Q3 2023 | 124 | $45.6M |
| Q2 2023 | 138 | $83.3M |
| Q1 2023 | 164 | $166.4M |
| Q4 2022 | 163 | $364.7M |
| Q3 2022 | 167 | $323.6M |
| Q2 2022 | 183 | $317.9M |
| Q1 2022 | 186 | $385.5M |
| Q4 2021 | 186 | $368.9M |
| Q3 2021 | 173 | $457.1M |
| Q2 2021 | 175 | $444.0M |
| Q1 2021 | 172 | $703.5M |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Tvardi Therapeutics, Inc.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Mirae Asset Global Investments Co., Ltd. | 21,214 | – | – | +21,214 | New |
| LGT Financial Advisors LLC | 0 | $0 | 0.00% | −183−100.0% | Sold out |
| Jacobs Levy Equity Management, Inc | 0 | $0 | 0.00% | −696,868−100.0% | Sold out |
| Dimensional Fund Advisors LP | 0 | $0 | 0.00% | −167,314−100.0% | Sold out |
| Bridgeway Capital Management, LLC | 0 | $0 | 0.00% | −141,200−100.0% | Sold out |
| Ameriprise Financial Inc | 0 | $0 | 0.00% | −117,471−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −93,385−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −85,742−100.0% | Sold out |
| MML Investors Services, LLC | 0 | $0 | 0.00% | −81,590−100.0% | Sold out |
| Susquehanna Portfolio Strategies, LLC | 0 | $0 | 0.00% | −57,071−100.0% | Sold out |
| Public Employees Retirement System of Ohio | 0 | $0 | 0.00% | −54,955−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −38,586−100.0% | Sold out |
| Russell Investments Group, Ltd. | 0 | $0 | 0.00% | −31,536−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −30,740−100.0% | Sold out |
| State of Wyoming | 0 | $0 | 0.00% | −27,690−100.0% | Sold out |
| Scientech Research LLC | 0 | $0 | 0.00% | −21,910−100.0% | Sold out |
| Wexford Capital LP | 0 | $0 | 0.00% | −17,090−100.0% | Sold out |
| Baader Bank INC | 0 | $0 | 0.00% | −17,376−100.0% | Sold out |
| Pathstone Holdings, LLC | 0 | $0 | 0.00% | −12,331−100.0% | Sold out |
| Pinnacle Associates Ltd | 0 | $0 | 0.00% | −11,727−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −10,930−100.0% | Sold out |
| Intrepid Financial Planning Group LLC | 0 | $0 | 0.00% | −10,500−100.0% | Sold out |
| The PNC Financial Services Group, Inc. | 0 | $0 | 0.00% | −70−100.0% | Sold out |
| Versant Capital Management, Inc | 0 | $0 | 0.00% | −55−100.0% | Sold out |
| Greenwood Gearhart Inc | 0 | $0 | 0.00% | −10−100.0% | Sold out |